Meridian Bioscience Stock

Meridian Bioscience Goodwill

The Goodwill of Meridian Bioscience (VIVO) as of Sep 11, 2026 is 116.30 M USD. In the previous year, Goodwill was 114.67 M USD — a change of 1.42% (higher).

Goodwill

116.30 MUSD

YoY

1.42%

Last updated:

Goodwill of Meridian Bioscience is 2026 116.30 M USD. Goodwill of Meridian Bioscience was 2025 114.67 M USD. It decreases by 1.42% higher compared to the previous year.

The Meridian Bioscience Goodwill history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Goodwill
Date
Goodwill
Jan 1, 2015
22.30 M USD
Jan 1, 2016
62.00 M USD
Jan 1, 2017
54.90 M USD
Jan 1, 2018
54.60 M USD
Jan 1, 2019
89.20 M USD
Jan 1, 2020
114.20 M USD
Jan 1, 2021
114.67 M USD
Jan 1, 2022
116.30 M USD
The Meridian Bioscience Goodwill history
YEARGoodwillYoY
116.30 MUSD+1.42%
114.67 MUSD+0.41%
114.20 MUSD+28.03%
89.20 MUSD+63.37%
54.60 MUSD-0.55%
54.90 MUSD-11.45%
62.00 MUSD+178.03%
22.30 MUSD-3.88%
23.20 MUSD
Access this data via the Eulerpool API

Meridian Bioscience Stock analysis

What does Meridian Bioscience do? Meridian Bioscience Inc. is a global company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. The company was founded in 1976 by William J. Motto and initially focused on the development of enzyme immunoassays (EIA). Over the years, the company has grown and diversified its product offerings, becoming a leading provider of diagnostic test kits for acute and chronic medical conditions, infectious diseases, gastrointestinal infections, and virology. The company's success is attributed to its diverse range of test kits in various medical areas, including immunology, infectious diseases, sexually transmitted diseases, gastroenterology, and virology. Additionally, Meridian Bioscience Inc. stays up-to-date with the latest technological advancements in biotechnology to ensure the fast and effective performance of its tests. The company operates globally, collaborating with universities, research institutions, government agencies, and distributors to ensure the worldwide distribution and marketing of its products. In summary, Meridian Bioscience Inc. is an innovative company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. Its wide range of products, including immunology products, infectious disease diagnostics, sexually transmitted disease test kits, gastroenterology, virology, and molecular diagnostics, coupled with advanced technologies, provides fast, accurate, and reliable diagnostic support. Meridian Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Meridian Bioscience stock

Goodwill of Meridian Bioscience is 116.30 M USD in 2026.

Goodwill of Meridian Bioscience changed from 114.67 M USD to 116.30 M USD, representing a 1.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Goodwill Meridian Bioscience since 2006 – with annual values, charts, and detailed analysis.

Goodwill is the premium paid above fair market value in an acquisition. It represents intangible value such as brand recognition, customer relationships, and intellectual property.

Goodwill's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill's Meridian Bioscience historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Meridian Bioscience

All Key Metrics — Meridian Bioscience